| The EF-G-like GTPase Snu114p regulates spliceosome dynamics mediated by Brr2p, a DExD/H box ATPase EC Small, SR Leggett, AA Winans, JP Staley Molecular cell 23 (3), 389-399, 2006 | 237 | 2006 |
| Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation R Popovic, E Martinez-Garcia, EG Giannopoulou, Q Zhang, Q Zhang, ... PLoS genetics 10 (9), e1004566, 2014 | 219 | 2014 |
| A role for ubiquitin in the spliceosome assembly pathway P Bellare, EC Small, X Huang, JA Wohlschlegel, JP Staley, ... Nature structural & molecular biology 15 (5), 444-451, 2008 | 190 | 2008 |
| Spatial mapping of protein composition and tissue organization: a primer for multiplexed antibody-based imaging JW Hickey, EK Neumann, AJ Radtke, JM Camarillo, RT Beuschel, ... Nature methods 19 (3), 284-295, 2022 | 182 | 2022 |
| UTX/KDM6A loss enhances the malignant phenotype of multiple myeloma and sensitizes cells to EZH2 inhibition T Ezponda, D Dupéré-Richer, CM Will, EC Small, N Varghese, T Patel, ... Cell reports 21 (3), 628-640, 2017 | 133 | 2017 |
| The splicing factor Prp43p, a DEAH box ATPase, functions in ribosome biogenesis NB Leeds, EC Small, SL Hiley, TR Hughes, JP Staley Molecular and cellular biology 26 (2), 513-522, 2006 | 133 | 2006 |
| Single-cell nucleosome mapping reveals the molecular basis of gene expression heterogeneity EC Small, L Xi, JP Wang, J Widom, JD Licht Proceedings of the National Academy of Sciences 111 (24), E2462-E2471, 2014 | 115 | 2014 |
| MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents MY Shah, E Martinez-Garcia, JM Phillip, AB Chambliss, R Popovic, ... Oncogene 35 (45), 5905-5915, 2016 | 92 | 2016 |
| A mutation in histone H2B represents a new class of oncogenic driver RL Bennett, A Bele, EC Small, CM Will, B Nabet, JA Oyer, X Huang, ... Cancer discovery 9 (10), 1438-1451, 2019 | 69 | 2019 |
| A mutation in histone H2B represents a new class of oncogenic driver. Cancer Discov. 2019; 9: 1438–1451. doi: 10.1158/2159-8290 RL Bennett, A Bele, EC Small, CM Will, B Nabet, JA Oyer, X Huang, ... CD-19-0393.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 12 | |
| Chromatin Immunoprecipitation (ChIP) to Study DNA–Protein Interactions EC Small, DN Maryanski, KL Rodriguez, KJ Harvey, MC Keogh, ... Proteomic Profiling: Methods and Protocols, 323-343, 2021 | 8 | 2021 |
| Loss of the histone demethylase UTX contributes to multiple myeloma and sensitizes cells to EZH2 inhibitors T Ezponda, R Popovic, Y Zheng, B Nabet, C Will, EC Small, ... Blood 124 (21), 611, 2014 | 8 | 2014 |
| MMSET dysregulates gene expression in myeloma through global and focal changes in H3K36 and H3K27 methylation R Popovic, E Martinez, Q Zhang, T Ezponda, Y Jiang, MY Shah, C Will, ... Blood 120 (21), 523, 2012 | 4 | 2012 |
| Mechanistic Insights into Mammalian Pre‐mRNA Splicing SM Fica, EC Small, M Mefford, JP Staley Posttranscriptional Gene Regulation: RNA Processing in Eukaryotes, 133-161, 2013 | 3 | 2013 |
| MMSET/WHSC1 enhances DNA damage repair leading to An increase in resistance to Chemotherapeutic agents MY Shah, E Martinez, R Popovic, T Ezponda, EC Small, C Will, P Neri, ... Blood 122 (21), 808, 2013 | 1 | 2013 |
| A novel method for developing recombinant histone PTM antibodies specific for ChIP EC Small, A Husain, AA Ketkar, A Johnstone, M Marunde, K Rodriguez, ... Cancer Research 80 (16_Supplement), 3644-3644, 2020 | | 2020 |
| KMD6A/UTX loss enhances the malignant phenotype of multiple myeloma and sensitizes cells to EZH2 inhibition D Dupere-Richer, T Ezponda, C Will, EC Small, N Varghese, P Tej, ... Clinical Cancer Research 23 (24_Supplement), 12-12, 2017 | | 2017 |
| Abstract B32: Loss of the histone demethylase UTX alters the gene expression prolife and contributes to the malignant phenotype of multiple myeloma cells. T Ezponda, R Popovic, Y Zheng, B Nabet, C Will, E Small, M Occhionorelli, ... Clinical Cancer Research 21 (17_Supplement), B32-B32, 2015 | | 2015 |
| Loss of the histone demethylase UTX alters the gene expression prolife and contributes to the malignant phenotype of multiple myeloma cells G Tonon, D Jonathan CLINICAL CANCER RESEARCH, 2015 | | 2015 |
| MMSET/WHSC1 Enhances DNA Damage Repair Leading To An Increase In Resistance To Chemotherapeutic Agents E Martinez, R Popovic, T Ezponda, EC Small, C Will, P Neri, NJ Bahlis, ... Blood 122 (21), 808-808, 2013 | | 2013 |
